Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Critical Care (London, England)|August 10, 2012
Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptorEvangelos J Giamarellos-Bourboulis, Anna Norrby-Teglund, Vassiliki Mylona, et al.The Journal of Antimicrobial Chemotherapy|December 3, 2013
Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trialEvangelos J Giamarellos-Bourboulis, Vassiliki Mylona, Anastasia Antonopoulou, et al.The Lancet. Respiratory Medicine|January 6, 2024
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trialEvangelos J Giamarellos-Bourboulis, Athanasios Siampanos, Amalia Bolanou, et al.Proceedings of the National Academy of Sciences of the United States of America|October 11, 2007
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humansBart Ferwerda, Matthew B B McCall, Santos Alonso, et al.Proceedings of the National Academy of Sciences of the United States of America|June 11, 2009
Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shockBart Ferwerda, Santos Alonso, Kathy Banahan, et al.Genome Medicine|January 14, 2021
Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patientsAnna C Aschenbrenner, Maria Mouktaroudi, Benjamin Krämer, et al.Nature Medicine|September 4, 2021
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trialEvdoxia Kyriazopoulou, Garyfallia Poulakou, Haralampos Milionis, et al.Pageof 4